B6N.129S2-Kif11tm1Much/Orl

Status

Available to order

EMMA IDEM:01814
Citation informationRRID:IMSR_EM:01814 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6N.129S2-Kif11tm1Much/Orl
Alternative nameB6;129-Knsl1 tmG3m
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolKif11tm1Much
Gene/Transgene symbolKif11

Information from provider

ProviderMichel Kress
Provider affiliationInstitut André Lwoff, CNRS UPR 1983
Genetic informationA 7.8 kb fragment of Knsl1 (Kif11) gene spanning from the PstI site in the intron downsteam the first coding exon to the XbaI site in the third coding exon, was deleted and replaced by an IRES-beta-geo-cassette, which has an upstream splicing acceptor, an internal ribosome entry site and a 3' polyadenylation signal.
Phenotypic informationThe Eg5 product of Knsl1 (Kif11) gene is a major kinesin motor protein involved in mitosis, and its absence leads to prometaphase block. Homozygous null mutants are not viable.
References
  • Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo.;Blangy A, Lane H A, d'Hérin P, Harper M, Kress M, Nigg E A, ;1995;Cell;83;1159-69; 8548803
  • The Knsl1 gene encoding the kinesin-related protein MmEg5 maps to mouse chromosome 19 and a related pseudogene maps to mouse chromosome 6.;Chauvière M, Poirier C, d'Hérin P, Kress M, ;2000;Cytogenetics and cell genetics;89;16-7; 10894929
  • Disruption of the mitotic kinesin Eg5 gene (Knsl1) results in early embryonic lethality.;Chauvière Muriel, Kress Chantal, Kress Michel, ;2008;Biochemical and biophysical research communications;372;513-9; 18474226

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • decreased embryo size / MGI
  • failure of embryo implantation / MGI
  • failure of blastocyst to hatch from the zona pellucida / MGI
  • embryonic lethality before implantation / MGI
MGI phenotypes (gene matching)
  • decreased embryo size / MGI
  • failure of embryo implantation / MGI
  • embryonic growth arrest / MGI
  • failure of blastocyst to hatch from the zona pellucida / MGI
  • embryonic lethality before implantation / MGI
  • abnormal preimplantation embryo development / MGI
  • embryonic lethality between implantation and somite formation, complete penetrance / MGI
  • embryonic lethality before implantation, incomplete penetrance / MGI
  • failure of morula compaction / MGI

Literature references

  • Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo.;Blangy A, Lane H A, d'Hérin P, Harper M, Kress M, Nigg E A, ;1995;Cell;83;1159-69; 8548803
  • The Knsl1 gene encoding the kinesin-related protein MmEg5 maps to mouse chromosome 19 and a related pseudogene maps to mouse chromosome 6.;Chauvière M, Poirier C, d'Hérin P, Kress M, ;2000;Cytogenetics and cell genetics;89;16-7; 10894929
  • Disruption of the mitotic kinesin Eg5 gene (Knsl1) results in early embryonic lethality.;Chauvière Muriel, Kress Chantal, Kress Michel, ;2008;Biochemical and biophysical research communications;372;513-9; 18474226

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).